Fund 1 Investments’s Cellebrite CLBT Stock Holding History

Fund 1 Investments’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-145,422	Closed	-$2.45M	–	78
2024 Q3	$2.45M	Buy	+145,422	New	+$2.16M	0.23%	42

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Fund 1 Investments's CLBT Position: Q4 2024 in Review

Fund 1 Investments sold out of Cellebrite (CLBT) in Q4 2024, closing a stake of 145,422 shares — an estimated $2.45M sold.

Fund 1 Investments first reported a position in CLBT in Q3 2024 and held it in 1 quarter. The position peaked at $2.45M in Q3 2024. 191 funds tracked by Wall St. Rank hold CLBT as of Q4 2024.

Fund 1 Investments reported no remaining Cellebrite position as of Q4 2024 after selling out during the quarter.
Fund 1 Investments sold 145,422 Cellebrite shares in Q4 2024, an estimated $2.45M.
Fund 1 Investments first reported a position in Cellebrite in Q3 2024 and held it in 1 quarter.
Fund 1 Investments's Cellebrite position peaked at $2.45M in Q3 2024.
191 funds tracked by Wall St. Rank held Cellebrite as of Q4 2024.

Based on Fund 1 Investments's 13F filing for Q4 2024, filed 14 Feb 2025.